Harvard University
Therapeutic HIV vaccines reviewed
Published in Law and Health Weekly, December 11th, 2004
According to a study from, "The goal of a therapeutic HIV vaccine is to attenuate HIV disease progression in those already infected. Our objective was to establish comparative efficacy and cost-effectiveness thresholds at which a therapeutic vaccine would make a valuable contribution to HIV care. Using an HIV computer simulation model, we compared therapeutic vaccination with HIV standard of care without vaccination. Input data were obtained from the literature."
"Base case and sensitivity analyses related to vaccine magnitude, penetrance, durability, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Accredo Health, Incorporated
Biotech company comments on CMS Remodulin reimbursement change - Albert Einstein College of Medicine
Immunoglobulin against Cryptococcus glucuronoxylomannan is protective - Chemotherapy
IMPAC announces support for CMS quality of care assessment in chemotherapy - Complementary & Alternative Medicine
Tennessee Senator plans to make legal medical marijuana a top priority - CryoLife, Inc.
Biosurgical-device company reports settlement of cases - Healthcare & Politics
Bush wants malpractice verdict limits, greater consumer role in healthcare - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
